✦ LIBER ✦

Bispecific antibody and its clinical applications in cancer

✍ Scribed by Yuanfu Xu; Chunzheng Yang; Zhenping Zhu

Publisher: Springer
Year: 2001
Tongue: English
Weight: 708 KB
Volume: 46
Category: Article
ISSN: 1001-6538
DOI: 10.1007/bf03183262

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical perspectives of bispecific anti

Clinical perspectives of bispecific antibodies in cancer

✍ G. C. de Gast; J. G. J. van de Winkel; Bert E. J. E. G. Bast 📂 Article 📅 1997 🏛 Springer-Verlag 🌐 English ⚖ 126 KB

Bispecific antibodies in cancer therapy

✍ David M Segal; George J Weiner; Louis M Weiner 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 58 KB

Abbreviations bsAb bispecific antibody

The Construction of a Functional Photoac

The Construction of a Functional Photoactivatable Cancer Targeting Bispecific Antibody Conjugate

✍ Stephen Thompson; Marie-Claude Fawcett; Colin H Self 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 198 KB

Molecular recognition in antibodies and

Molecular recognition in antibodies and its application

✍ M. C. Tedford; W. H. Stimson 📂 Article 📅 1991 🏛 Springer 🌐 English ⚖ 962 KB

Bispecific antibodies retarget murine T

Bispecific antibodies retarget murine T cell cytotoxicity against syngeneic breast cancer in vitro and in vivo

✍ M. Belen Moreno; Julie A. Titus; Michael S. Cole; J. Yun Tso; Nhat Le; Chang H. 📂 Article 📅 1995 🏛 Springer-Verlag 🌐 English ⚖ 946 KB

Preclinical and clinical data with bispe

Preclinical and clinical data with bispecific antibodies recruiting myeloid effector cells for tumor therapy

✍ H.H van Ojik; T Valerius 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 199 KB

Bispecific antibodies constitute a novel approach to improve antibody efficacy. In vitro, constructs to recruit myeloid effector cells have been extensively investigated, and first animal data in human Fc receptor transgenic mice confirmed their promising therapeutic potential. Clinical experience w